Cargando…
The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation
Background: The taste of oral liquid dosage forms is a crucial factor that impacts paediatric patient compliance. The electronic tongue (ET) is an emerging tool that could be useful in taste assessment in order to minimize the involvement of humans in such evaluations. Purpose: The aim of this study...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855094/ https://www.ncbi.nlm.nih.gov/pubmed/29401675 http://dx.doi.org/10.3390/s18020454 |
_version_ | 1783307029770665984 |
---|---|
author | Abu-Khalaf, Nawaf Zaid, Abdel Naser Jaradat, Nidal AlKilany, Alaaldin Abu Rumaila, Basima Al Ramahi, Rowa Shweiki, Shrouq Nidal, Safaa Surakhi, Nibal |
author_facet | Abu-Khalaf, Nawaf Zaid, Abdel Naser Jaradat, Nidal AlKilany, Alaaldin Abu Rumaila, Basima Al Ramahi, Rowa Shweiki, Shrouq Nidal, Safaa Surakhi, Nibal |
author_sort | Abu-Khalaf, Nawaf |
collection | PubMed |
description | Background: The taste of oral liquid dosage forms is a crucial factor that impacts paediatric patient compliance. The electronic tongue (ET) is an emerging tool that could be useful in taste assessment in order to minimize the involvement of humans in such evaluations. Purpose: The aim of this study is to evaluate the taste of commercially available clarithromycin (CM) oral pharmaceutical suspensions in the Palestinian market. Method: Commercially available CM suspensions (the brand Klacid(®) and two generic K1 and K2) were assayed using the high performance liquid chromatography (HPLC) method. Then, the taste of these products was assessed using alpha-astree ET. In addition, an in vivo taste assessment was conducted on paediatric patients by a hedonic panel test. Moreover, volunteering community pharmacists were asked to rank the taste of these three products according to their experience from the best to the worst. Results: All suspension products had a CM concentration not less than 98% of the label amount. The ET results coupled with the principal component analysis (PCA) showed a very clear discrimination of the samples with different distances between groups (p-values < 0.001). Suspensions were in the following order in terms of taste: Klacid(®) > K1 > K2. Moreover, The pattern discrimination index between (K1 and Klacid(®)), (K1 and K2) and (Klacid(®) and K2) were 8.81%, 65.75%, and 71.94%, respectively which suggests that K1 and Klacid(®) are the most similar preparations in terms of taste. Interestingly, these results were in excellent agreement with the pharmacist ranking and patient acceptance test. Conclusions: The evaluated preparations showed significantly different taste within the order of Klacid(®) > K1 > K2, as suggested by both the ET and in vivo results. Moreover, our results confirm the capability of alpha-astree ET in the taste assessment of oral suspensions and in predicting volunteer responses, which highlights its beneficial use as an in vitro taste assessment tool and as an alternative to human-based taste evaluations. |
format | Online Article Text |
id | pubmed-5855094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-58550942018-03-20 The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation Abu-Khalaf, Nawaf Zaid, Abdel Naser Jaradat, Nidal AlKilany, Alaaldin Abu Rumaila, Basima Al Ramahi, Rowa Shweiki, Shrouq Nidal, Safaa Surakhi, Nibal Sensors (Basel) Article Background: The taste of oral liquid dosage forms is a crucial factor that impacts paediatric patient compliance. The electronic tongue (ET) is an emerging tool that could be useful in taste assessment in order to minimize the involvement of humans in such evaluations. Purpose: The aim of this study is to evaluate the taste of commercially available clarithromycin (CM) oral pharmaceutical suspensions in the Palestinian market. Method: Commercially available CM suspensions (the brand Klacid(®) and two generic K1 and K2) were assayed using the high performance liquid chromatography (HPLC) method. Then, the taste of these products was assessed using alpha-astree ET. In addition, an in vivo taste assessment was conducted on paediatric patients by a hedonic panel test. Moreover, volunteering community pharmacists were asked to rank the taste of these three products according to their experience from the best to the worst. Results: All suspension products had a CM concentration not less than 98% of the label amount. The ET results coupled with the principal component analysis (PCA) showed a very clear discrimination of the samples with different distances between groups (p-values < 0.001). Suspensions were in the following order in terms of taste: Klacid(®) > K1 > K2. Moreover, The pattern discrimination index between (K1 and Klacid(®)), (K1 and K2) and (Klacid(®) and K2) were 8.81%, 65.75%, and 71.94%, respectively which suggests that K1 and Klacid(®) are the most similar preparations in terms of taste. Interestingly, these results were in excellent agreement with the pharmacist ranking and patient acceptance test. Conclusions: The evaluated preparations showed significantly different taste within the order of Klacid(®) > K1 > K2, as suggested by both the ET and in vivo results. Moreover, our results confirm the capability of alpha-astree ET in the taste assessment of oral suspensions and in predicting volunteer responses, which highlights its beneficial use as an in vitro taste assessment tool and as an alternative to human-based taste evaluations. MDPI 2018-02-03 /pmc/articles/PMC5855094/ /pubmed/29401675 http://dx.doi.org/10.3390/s18020454 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Abu-Khalaf, Nawaf Zaid, Abdel Naser Jaradat, Nidal AlKilany, Alaaldin Abu Rumaila, Basima Al Ramahi, Rowa Shweiki, Shrouq Nidal, Safaa Surakhi, Nibal The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation |
title | The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation |
title_full | The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation |
title_fullStr | The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation |
title_full_unstemmed | The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation |
title_short | The Taste of Commercially Available Clarithromycin Oral Pharmaceutical Suspensions in the Palestinian Market: Electronic Tongue and In Vivo Evaluation |
title_sort | taste of commercially available clarithromycin oral pharmaceutical suspensions in the palestinian market: electronic tongue and in vivo evaluation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855094/ https://www.ncbi.nlm.nih.gov/pubmed/29401675 http://dx.doi.org/10.3390/s18020454 |
work_keys_str_mv | AT abukhalafnawaf thetasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT zaidabdelnaser thetasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT jaradatnidal thetasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT alkilanyalaaldin thetasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT aburumailabasima thetasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT alramahirowa thetasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT shweikishrouq thetasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT nidalsafaa thetasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT surakhinibal thetasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT abukhalafnawaf tasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT zaidabdelnaser tasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT jaradatnidal tasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT alkilanyalaaldin tasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT aburumailabasima tasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT alramahirowa tasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT shweikishrouq tasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT nidalsafaa tasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation AT surakhinibal tasteofcommerciallyavailableclarithromycinoralpharmaceuticalsuspensionsinthepalestinianmarketelectronictongueandinvivoevaluation |